Citation 63224

KURUSU,K: OHBA,K: ARAI,T: FUKUSHIMA,K:. (1987). NEW PEPTIDE ANTIBIOTICS LI-F03, F04, F05, F07, AND F08, PRODUCED BY BACILLUS POLYMYXA. I. ISOLATION AND CHARACTERIZATION.. 40(11)

Citation Details

Title	NEW PEPTIDE ANTIBIOTICS LI-F03, F04, F05, F07, AND F08, PRODUCED BY BACILLUS POLYMYXA. I. ISOLATION AND CHARACTERIZATION.
Authors	KURUSU,K: OHBA,K: ARAI,T: FUKUSHIMA,K:
Year	1987
Volume	40
Issue	11

Summary

Year: 1987

Journal: Unknown

Organisms and Their Experiments (1)

Bacillus polymyxa (BACILLACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	UV SPECTRUM GIVEN FORINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BACILLUS ANTIBIOTIC LI-F03	None
2	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F03	ACTIVE
3	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F03	ACTIVE
4	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BACILLUS ANTIBIOTIC LI-F03	.
5	Not specified	INFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BACILLUS ANTIBIOTIC LI-F04	None
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F04	ACTIVE
7	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F04	ACTIVE
8	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BACILLUS ANTIBIOTIC LI-F04	.
9	Not specified	INFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BACILLUS ANTIBIOTIC LI-F05	None
10	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F05	ACTIVE
11	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F05	ACTIVE
12	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BACILLUS ANTIBIOTIC LI-F05	.
13	Not specified	INFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BACILLUS ANTIBIOTIC LI-F07	None
14	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F07	ACTIVE
15	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F07	ACTIVE
16	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BACILLUS ANTIBIOTIC LI-F07	.
17	Not specified	INFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BACILLUS ANTIBIOTIC LI-F08	None
18	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F08	ACTIVE
19	ANTIFUNGAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	BACILLUS ANTIBIOTIC LI-F08	ACTIVE
20	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	BACILLUS ANTIBIOTIC LI-F08	.

Citation 63224

Citation Details

Summary

Organisms and Their Experiments (1)

Bacillus polymyxa (BACILLACEAE)

Show SPARQL Queries (1)

Query 1